Similar Search Results

Effects of Trips Agreement on Indian Pharmaceutical Patenting

Pai, Rimpa - 2023

The TRIPS Agreement obligated India to amend its patent laws to meet the minimum standard of patent protection and … patentability. In 2005, India amended its Patent Act to comply with TRIPS, which resulted in the removal of several provisions that … India. It discusses the challenges faced by the Indian pharmaceutical industry and the strategies adopted by India to …

Persistent link: https://www.econbiz.de/10014347932

Patent Amendment Act 2005 : Its Effect on Indian Pharmaceutical Company

Garai, Prantik - 2014

India has a history of the patent acts starting form 1911. All happened was pre independence. The Patent Act, 1970 was … the first patent act to the independent India. It had provision for only process patent but did not have any provision for …. After India signed the TRIPS it was obliged to amend the patent act and introduce the product patent. The researcher in the …

Persistent link: https://www.econbiz.de/10014206237

Firm-level productivity and its determinants in the Indian pharmaceutical industry

Das, Subhrabaran; Hoque, Ariful - In: Decision : official journal of Indian Institute of … 50 (2023) 4, pp. 439-459

Persistent link: https://www.econbiz.de/10014518871

The introduction of pharmaceutical product patents in India : "heartless exploitation of the poor and suffering"?

Lanjouw, Jean Olson - 1997

Persistent link: https://www.econbiz.de/10000983441

COVID-19 vaccines and the role of patents

Larson, Kelli - In: International journal of intellectual property … 11 (2021) 4, pp. 486-491

Persistent link: https://www.econbiz.de/10012800211

Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products : the case of Sri Lanka's patent law

Fernando, Ruwan - 2023

Apart from the basic statutory definition in section 65 of the Intellectual Property Act of Sri Lanka, there do not appear to be any detailed statutory guidelines or judicial decisions to provide any framework for the assessment of inventive step in Sri Lanka. The current statutory definition is...

Persistent link: https://www.econbiz.de/10014324836

Patent settlements in the pharmaceutical industry : what can we learn from economic analysis?

Frank, Jonas Severin; Kerber, Wolfgang - 2016

Patent settlements between originator and generic firms in the pharmaceutical industry have been challenged by antitrust and competition authorities in the U.S. and the EU. Particularly settlements with large "reverse payments" to generic firms raise the concern of collusive behaviour for...

Persistent link: https://www.econbiz.de/10011408141

Big pharma and monopoly capitalism: a long-term view

Dosi, Giovanni; Marengo, Luigi; Staccioli, Jacopo; … - 2021

Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...

Persistent link: https://www.econbiz.de/10012604733

Access to medicines after TRIPS : is compulsory licensing an effective mechanism to lower drug prices? ; a review of the existing evidence

Urias, Eduardo; Ramani, Shyama V. - In: Journal of International Business Policy : JIBP 3 (2020) 4, pp. 367-384

Persistent link: https://www.econbiz.de/10012405471

Biases in patent examination and firms' responses : evidence from the pharmaceutical industry

Yu, Fei; Wu, Yanrui; Chen, Jin - In: China economic journal : the official journal of the … 9 (2016) 2, pp. 101-115

Persistent link: https://www.econbiz.de/10011585308